Edition:
India

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

625.85INR
16 Jan 2018
Change (% chg)

Rs1.45 (+0.23%)
Prev Close
Rs624.40
Open
Rs626.00
Day's High
Rs633.80
Day's Low
Rs623.15
Volume
1,200,060
Avg. Vol
1,034,277
52-wk High
Rs972.95
52-wk Low
Rs525.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun 23,630.00 11.534
FY 2017 Mar '17 24,571.80 7.489
Dec 25,350.10 16.250
Sep 22,241.10 7.774
Jun 19,693.80 7.720
FY 2016 Mar '16 23,066.80 6.519
Dec 17,783.00 6.030
Sep 19,093.60 7.010
Jun 16,477.40 6.768
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 22,429.70 22,429.70 22,429.70 --
Quarter Ending Sep-18 1 24,754.00 24,754.00 24,754.00 --
Year Ending Mar-18 27 93,674.20 98,398.10 90,132.60 105,078.00
Year Ending Mar-19 30 104,973.00 125,734.00 97,777.00 117,647.00
Earnings (per share)
Quarter Ending Jun-18 2 9.67 9.84 9.50 --
Quarter Ending Sep-18 2 9.47 10.36 8.58 --
Year Ending Mar-18 28 36.46 44.10 28.02 52.90
Year Ending Mar-19 31 43.05 56.70 35.63 57.42
LT Growth Rate (%) 1 10.62 10.62 10.62 24.21
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 14.21 31.11 32.89
P/E High - Last 5 Yrs. 44.88 40.91 45.60
P/E Low - Last 5 Yrs. 20.22 23.78 24.32
Beta 0.27 0.90 0.89
Price to Sales (TTM) 1.80 3.94 5.41
Price to Book (MRQ) -- 4.82 5.38
Price to Tangible Book (MRQ) -- 5.53 6.76
Price to Cash Flow (TTM) 11.58 23.03 23.42
% Owned Institutions -- 1.12 1.81

Dividends

  Company industry sector
Dividend Yield 0.33 1.56 1.50
Dividend Yield - 5 Year Avg 0.29 1.57 1.51
Dividend 5 Year Growth Rate 0.00 4.35 5.22
Payout Ratio(TTM) 5.59 45.69 43.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 19.99 3.57 9.01
Sales (TTM) vs TTM 1 Yr. Ago 21.15 4.67 5.40
Sales - 5 Yr. Growth Rate 17.97 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 49.41 16.27 19.39
EPS (TTM) vs TTM 1 Yr. Ago 57.35 -- --
EPS - 5 Yr. Growth Rate 18.22 9.87 10.80
Capital Spending - 5 Yr. Growth Rate 21.27 15.28 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) -- 2.88 2.97
LT Debt to Equity (MRQ) -- 9.70 11.90
Total Debt to Equity (MRQ) -- 13.67 16.16
Interest Coverage (TTM) 6.69 36.31 33.26

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 71.69 55.22 54.87
Gross Margin - 5 Yr. Avg. 67.81 52.38 52.46
EBITD Margin (TTM) 23.33 -- --
EBITD - 5 Yr. Avg 20.85 18.52 15.31
Operating Margin (TTM) 19.61 14.55 7.77
Operating Margin - 5 Yr. Avg. 15.96 14.46 10.80
Pre-Tax Margin (TTM) 16.60 14.99 8.57
Pre-Tax Margin - 5 Yr. Avg. 13.24 14.78 11.21
Net Profit Margin (TTM) 12.70 11.26 4.88
Net Profit Margin - 5 Yr. Avg. 10.15 11.11 7.51
Effective Tax Rate (TTM) 23.51 23.19 23.08
Effective Tax Rate - 5 Yr. Avg. 23.32 23.42 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 7,387,447 950,005,605 859,857,503
Net Income/Employee (TTM) 937,855 111,774,344 101,151,730
Receivable Turnover (TTM) -- 5.61 5.76
Inventory Turnover (TTM) -- 2.57 3.33
Asset Turnover (TTM) -- 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.41 10.99
Return on Assets - 5 Yr. Avg. 8.04 12.99 12.42
Return on Investment (TTM) -- 14.85 14.44
Return on Investment - 5 Yr. Avg. 12.35 16.99 16.26
Return on Equity (TTM) -- 16.31 16.10
Return on Equity - 5 Yr. Avg. 23.02 18.05 17.54
  1 Year 3 Year 5 Year
Sales % 20.08 15.22 17.97
EPS (TTM) % 48.44 25.24 18.22
Dividend % 0.00 0.00 0.00
Note: Units in Millions of US Dollars

Performance for Glenmark Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 5.55 5.13 99 25
13 Week -7.94 -9.25 99 35
26 Week -29.02 -33.73 71 30
52 Week -33.69 -41.42 65 12
YTD -31.07 -42.31 67 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 22.37%
# of Holders: 115
Total Shares Held: 63,130,600
3 Mo. Net Change: 3,258,035
# New Positions: 3
# Closed Positions: 3
# Increased Positions: 31
# Reduced Positions: 19
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.